Citadel Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.86M Sell
90,000
-7,000
-7% -$301K ﹤0.01% 4782
2025
Q4
$4.25M Sell
97,000
-55,600
-36% -$2.3M ﹤0.01% 4542
2025
Q3
$6.3M Buy
152,600
+54,500
+56% +$2.19M ﹤0.01% 3945
2025
Q2
$4.32M Sell
98,100
-26,000
-21% -$1.04M ﹤0.01% 4369
2025
Q1
$4.58M Sell
124,100
-8,300
-6% -$296K ﹤0.01% 4016
2024
Q4
$4.41M Buy
132,400
+15,300
+13% +$496K ﹤0.01% 4163
2024
Q3
$3.04M Buy
117,100
+26,000
+29% +$646K ﹤0.01% 4757
2024
Q2
$2.05M Sell
91,100
-2,100
-2% -$46.6K ﹤0.01% 5254
2024
Q1
$2.21M Sell
93,200
-46,800
-33% -$1.04M ﹤0.01% 5333
2023
Q4
$3.36M Sell
140,000
-11,800
-8% -$257K ﹤0.01% 4461
2023
Q3
$3.32M Buy
151,800
+75,200
+98% +$1.57M ﹤0.01% 4306
2023
Q2
$1.46M Sell
76,600
-25,800
-25% -$497K ﹤0.01% 5716
2023
Q1
$1.99M Sell
102,400
-30,800
-23% -$537K ﹤0.01% 5384
2022
Q4
$2.14M Buy
133,200
+5,600
+4% +$91.3K ﹤0.01% 5350
2022
Q3
$2M Sell
127,600
-5,300
-4% -$102K ﹤0.01% 5589
2022
Q2
$2.77M Buy
132,900
+18,600
+16% +$383K ﹤0.01% 4904
2022
Q1
$2.59M Sell
114,300
-9,700
-8% -$189K ﹤0.01% 5509
2021
Q4
$2.27M Sell
124,000
-201,300
-62% -$3.85M ﹤0.01% 5950
2021
Q3
$6.88M Buy
325,300
+23,700
+8% +$440K ﹤0.01% 3713
2021
Q2
$5.5M Buy
301,600
+167,200
+124% +$3.9M ﹤0.01% 4230
2021
Q1
$3.04M Buy
134,400
+7,500
+6% +$169K ﹤0.01% 5424
2020
Q4
$2.55M Sell
126,900
-96,400
-43% -$2.02M ﹤0.01% 4854
2020
Q3
$5.46M Buy
223,300
+129,900
+139% +$3.03M ﹤0.01% 3023
2020
Q2
$2.22M Sell
93,400
-62,600
-40% -$1.45M ﹤0.01% 4383
2020
Q1
$2.69M Sell
156,000
-132,400
-46% -$2.42M ﹤0.01% 3651
2019
Q4
$5.08M Buy
288,400
+60,800
+27% +$1.03M ﹤0.01% 3057
2019
Q3
$4.03M Buy
227,600
+79,200
+53% +$1.6M ﹤0.01% 3406
2019
Q2
$3.17M Sell
148,400
-19,100
-11% -$400K ﹤0.01% 3768
2019
Q1
$3.99M Sell
167,500
-133,800
-44% -$3.05M ﹤0.01% 3310
2018
Q4
$5.93M Buy
301,300
+14,900
+5% +$266K ﹤0.01% 2553
2018
Q3
$5.08M Buy
286,400
+31,500
+12% +$614K ﹤0.01% 2985
2018
Q2
$5.49M Sell
254,900
-108,800
-30% -$2.25M ﹤0.01% 2636
2018
Q1
$8.06M Buy
363,700
+33,000
+10% +$912K ﹤0.01% 1934
2017
Q4
$10.1M Buy
330,700
+54,100
+20% +$1.44M 0.01% 1728
2017
Q3
$6.7M Buy
276,600
+119,700
+76% +$3.19M 0.01% 1984
2017
Q2
$3.86M Buy
156,900
+22,900
+17% +$485K ﹤0.01% 2387
2017
Q1
$2.9M Sell
134,000
-29,700
-18% -$604K ﹤0.01% 2625
2016
Q4
$2.44M Sell
163,700
-36,600
-18% -$528K ﹤0.01% 2720
2016
Q3
$2.56M Buy
200,300
+102,400
+105% +$1.11M ﹤0.01% 2676
2016
Q2
$765K Buy
97,900
+14,600
+18% +$84.1K ﹤0.01% 3918
2016
Q1
$333K Buy
83,300
+31,500
+61% +$133K ﹤0.01% 4962
2015
Q4
$292K Sell
51,800
-54,100
-51% -$303K ﹤0.01% 5247
2015
Q3
$594K Buy
105,900
+61,000
+136% +$332K ﹤0.01% 4554
2015
Q2
$169K Buy
44,900
+23,800
+113% +$77.4K ﹤0.01% 6521
2015
Q1
$54K Sell
21,100
-74,600
-78% -$173K ﹤0.01% 7330
2014
Q4
$138K Sell
95,700
-36,300
-28% -$56.6K ﹤0.01% 6359
2014
Q3
$202K Buy
132,000
+27,500
+26% +$88.3K ﹤0.01% 5717
2014
Q2
$354K Buy
104,500
+27,100
+35% +$93.6K ﹤0.01% 4826
2014
Q1
$274K Buy
77,400
+67,400
+674% +$459K ﹤0.01% 5124
2013
Q4
$61K Sell
10,000
-3,100
-24% -$17.1K ﹤0.01% 5927
2013
Q3
$76K Buy
13,100
+10,500
+404% +$54.3K ﹤0.01% 5540
2013
Q2
$12K Buy
+2,600
New +$12.3K ﹤0.01% 6192

Other funds holding EXEL

Citadel Advisors's EXEL Position: Q1 2026 in Review

Citadel Advisors increased its Exelixis (EXEL) stake by 67% in Q1 2026, buying an estimated $14M and bringing the position to 812,195 shares worth $34.8M. The position accounts for 0.01% of the portfolio, ranked #1710.

Citadel Advisors first reported a position in EXEL in Q2 2013 and has held it in 49 quarters since. The position peaked at $82.6M in Q1 2021. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Citadel Advisors held 812,195 shares of Exelixis worth $34.8M as of Q1 2026.
  • Citadel Advisors bought 326,318 Exelixis shares in Q1 2026, an estimated $14M.
  • Exelixis made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1710 holding.
  • Citadel Advisors first reported a position in Exelixis in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Exelixis position peaked at $82.6M in Q1 2021.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.